BioCryst Pharmaceuticals Inc. logo

BioCryst Pharmaceuticals Inc. (BCRX)

Market Closed
15 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
7. 59
+0.02
+0.33%
$
1.49B Market Cap
- P/E Ratio
0% Div Yield
4,397,996 Volume
-0.62 Eps
$ 7.57
Previous Close
Day Range
7.43 7.92
Year Range
6 11.31
Want to track BCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 69 days
Name Time Cons. EPS Eps
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
25 Feb 2026 (In 2 months)
0.04
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
23 Feb 2026 (In 2 months)
0.04
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
3 Nov 2025
0.05
0.16
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
29 Oct 2025
0.03
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
31 Jul 2025
0.01
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
5 May 2025
-
0
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
24 Feb 2025
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
31 Oct 2024
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
1 Aug 2024
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
14 May 2024
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
19 Feb 2024
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
2 Nov 2023
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
7 Nov 2016
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
4 Aug 2016
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
5 May 2016
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
23 Feb 2016
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
5 Nov 2015
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
7 Aug 2015
-
0.06
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
8 May 2015
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
18 Feb 2015
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
6 Nov 2014
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
5 Aug 2014
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
8 May 2014
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
26 Feb 2014
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
5 Nov 2013
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
8 Aug 2013
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
7 May 2013
-
-
BioCryst Pharmaceuticals Inc. logo
BCRX BioCryst Pharmaceuticals Inc.
19 Feb 2013
-
-

BCRX Earnings Reports FAQ

What is the earnings per share (EPS) for BCRX?

The current EPS is -0.62.

What is the company's earnings growth rate?

Over the past 13 years, the earnings growth rate has been approximately 10.31%, reflecting the BCRX's performance and NASDAQ (NGS) market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-23, based on the BCRX's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 0.16 per share, reported on 2025-11-03. For dividend history, visit the BCRX Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 47.47, calculated based on the most recent stock price of $7.59.